Processa Pharmaceuticals PCSA Estimates

NASDAQ PCSA
$1.79 -0.05 (-2.45%)
As of: Sep 29, 2026 · 3:57 PM EDT
Analyst Estimates

Processa Pharmaceuticals, Inc. Annual Revenue Estimates

Periods 8
Next Period 2022
Consensus 0.00

Analysts expect Processa Pharmaceuticals, Inc. to report revenue of 0.00 for 2022, against a range of 0.00 to 0.00. The most recent reported year, 2021, came in at 0.00.

Metric 20212022202320252026202720282029
Reported (Actual) 0.00--
High Estimate 0.000.000.00
Low Estimate 0.000.000.00
Consensus Estimate 0.000.000.00
Analyst Estimates

Processa Pharmaceuticals, Inc. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 26
Consensus -0.94

Analysts expect Processa Pharmaceuticals, Inc. to report earnings per share of -0.94 for Q3 26, against a range of -1.03 to -0.85. The most recent reported quarter, Q2 26, came in at -1.19, a 26.3% miss against the -0.94 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -25.75-19.38-7.50-6.25-1.81-2.57-1.29-1.19--------
High Estimate -24.71-19.59-12.02-4.82-2.04-1.22-0.87-0.91-0.85-0.65-1.47-2.41-0.74-0.39-1.35-2.97
Low Estimate -28.31-21.13-13.72-5.88-2.24-1.36-1.01-0.97-1.03-0.79-1.69-2.75-0.84-0.45-1.63-3.23
Consensus Estimate -26.51-20.36-12.87-5.35-2.14-1.29-0.94-0.94-0.94-0.72-1.58-2.58-0.79-0.42-1.49-3.10

Processa Pharmaceuticals, Inc. Estimates API

Pull Wall Street consensus for Processa Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=PCSA&mode=revenue&api_key=YOUR_API_KEY